(RTTNews) - Origin Bancorp, Inc. (OBK) reported a profit for its fourth quarter that Increased, from last year The company's earnings totaled $29.52 million, or $0.95 per share. This compares with $14.27 million, or $0.46 per share, last year. The company's revenue for the period rose 10.6% to $86.69 million from $78.35 million last year. Origin Bancorp, Inc. earnings at a glance (GAAP) : -Earning...
(RTTNews) - Origin Bancorp, Inc. (OBK) reported a profit for its fourth quarter that Increased, from last year The company's earnings totaled $29.52 million, or $0.95 per share. This compares with $14.27 million, or $0.46 per share, last year. The company's revenue for the period rose 10.6% to $86.69 million from $78.35 million last year. Origin Bancorp, Inc. earnings at a glance (GAAP) : -Earnings: $29.52 Mln. vs. $14.27 Mln. last year. -EPS: $0.95 vs. $0.46 last year. -Revenue: $86.69 Mln vs. $78.35 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
(RTTNews) - Hawthorn bancshares inc. (HWBK) revealed a profit for its fourth quarter that Increased, from last year The company's bottom line came in at $6.19 million, or $0.90 per share. This compares with $4.60 million, or $0.66 per share, last year. The company's revenue for the period rose 12.2% to $21.17 million from $18.87 million last year. Hawthorn bancshares inc. earnings at a glance (GAA...
(RTTNews) - Hawthorn bancshares inc. (HWBK) revealed a profit for its fourth quarter that Increased, from last year The company's bottom line came in at $6.19 million, or $0.90 per share. This compares with $4.60 million, or $0.66 per share, last year. The company's revenue for the period rose 12.2% to $21.17 million from $18.87 million last year. Hawthorn bancshares inc. earnings at a glance (GAAP) : -Earnings: $6.19 Mln. vs. $4.60 Mln. last year. -EPS: $0.90 vs. $0.66 last year. -Revenue: $21.17 Mln vs. $18.87 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four people injured in Hong Kong’s deadly Tai Po fire remain in hospital in stable condition, while 75 others have been discharged as of Thursday, according to health authorities. A government spokesman said that healthcare staff would continue to provide appropriate treatment and care to the patients from the Wang Fuk Court fire, which claimed at least 168 lives and injured 79 in November last ye...
Four people injured in Hong Kong’s deadly Tai Po fire remain in hospital in stable condition, while 75 others have been discharged as of Thursday, according to health authorities. A government spokesman said that healthcare staff would continue to provide appropriate treatment and care to the patients from the Wang Fuk Court fire, which claimed at least 168 lives and injured 79 in November last year. “All those injured in the fire and admitted to public hospitals under the Hospital Authority will receive full fee waivers for necessary treatment, including drugs and medical devices, throughout their recovery,” he said. Advertisement He also said the authority had provided healthcare services to about 1,900 residents affected by the fire. Under the relief measures, all residents of the estate’s eight blocks, including foreign domestic helpers, were eligible for full medical fee waivers until December 31. Advertisement The waiver covers inpatient services, family medicine and specialist outpatient clinics, day hospitals, community services and Chinese medicine clinics that also serve as training and research centres under the authority.
(RTTNews) - GBank Financial Holdings Inc. (GBFH) reported a profit for its fourth quarter that Increases, from the same period last year The company's bottom line totaled $7.39 million, or $0.51 per share. This compares with $5.24 million, or $0.37 per share, last year. Excluding items, GBank Financial Holdings Inc. reported adjusted earnings of $7.59 million or $0.52 per share for the period. The...
(RTTNews) - GBank Financial Holdings Inc. (GBFH) reported a profit for its fourth quarter that Increases, from the same period last year The company's bottom line totaled $7.39 million, or $0.51 per share. This compares with $5.24 million, or $0.37 per share, last year. Excluding items, GBank Financial Holdings Inc. reported adjusted earnings of $7.59 million or $0.52 per share for the period. The company's revenue for the period rose 15.9% to $22.73 million from $19.61 million last year. GBank Financial Holdings Inc. earnings at a glance (GAAP) : -Earnings: $7.39 Mln. vs. $5.24 Mln. last year. -EPS: $0.51 vs. $0.37 last year. -Revenue: $22.73 Mln vs. $19.61 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
(RTTNews) - Landmark Bancorp Inc. (LARK) reported earnings for its fourth quarter that Increased, from last year The company's earnings came in at $4.74 million, or $0.77 per share. This compares with $3.28 million, or $0.54 per share, last year. The company's revenue for the period rose 10.0% to $20.84 million from $18.95 million last year. Landmark Bancorp Inc. earnings at a glance (GAAP) : -Ear...
(RTTNews) - Landmark Bancorp Inc. (LARK) reported earnings for its fourth quarter that Increased, from last year The company's earnings came in at $4.74 million, or $0.77 per share. This compares with $3.28 million, or $0.54 per share, last year. The company's revenue for the period rose 10.0% to $20.84 million from $18.95 million last year. Landmark Bancorp Inc. earnings at a glance (GAAP) : -Earnings: $4.74 Mln. vs. $3.28 Mln. last year. -EPS: $0.77 vs. $0.54 last year. -Revenue: $20.84 Mln vs. $18.95 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
To get John Authers’ newsletter delivered directly to your inbox, sign up here . Today’s Points: The FOMC left rates unchanged, and didn’t rock the boat . Bessent says the US wants a strong dollar , and isn’t propping up the yen. The dollar pegged back while gold’s stratospheric rally continued. Hyperscalers’ results diverged; markets loved Meta , but not Microsoft . AND: A chance to listen in on ...
To get John Authers’ newsletter delivered directly to your inbox, sign up here . Today’s Points: The FOMC left rates unchanged, and didn’t rock the boat . Bessent says the US wants a strong dollar , and isn’t propping up the yen. The dollar pegged back while gold’s stratospheric rally continued. Hyperscalers’ results diverged; markets loved Meta , but not Microsoft . AND: A chance to listen in on the TACO Trade . FOMC You Later It’s a curse to live in interesting times . Central bankers have certainly learned that of late as the Federal Reserve and its governance have grown into a hot-button political issue. Generally, they want to keep things dull and predictable to minimize the risk of financial accidents. On that basis, Jerome Powell is probably happy with his day’s work. In the midst of the greatest turmoil for the institution in decades, he and his colleagues on the Federal Open Market Committee conjured a truly uninteresting announcement on monetary policy. Rates are unchanged. There is no new steer as to the future. There are no new adjustments to the balance sheet. And there are no new projections or dot plots from the committee members. When Powell faced the press, he declined to answer a series of questions on the political issues at the top of everyone’s minds. This is what happened to the main asset classes over the course of the trading day, with the moment of the FOMC decision marked with a vertical line. It would be hard to see that anything happened at that time without the marker: Rather than go into the normal drill for an FOMC day and explore the nuances with a fine-tooth comb, the main points of interest are: More Hawkish Than Dovish Powell left all options open, but his persistence in describing inflation as elevated, while sounding surprisingly confident about the employment market, marks him as tending slightly in the hawkish direction. As gold rose, while the dollar and 10-year yields fell in the late afternoon, the market didn’t necessarily ...
Key Points Texas Instruments stock rose nearly 10% despite missing Q4 revenue and earnings estimates. Data center orders jumped 70% year over year, turning a small niche business into a major growth story. TI's domestic manufacturing shields it from the tariff concerns plaguing competitors with Asian supply chains. 10 stocks we like better than Texas Instruments › Shares of Texas Instruments (NASD...
Key Points Texas Instruments stock rose nearly 10% despite missing Q4 revenue and earnings estimates. Data center orders jumped 70% year over year, turning a small niche business into a major growth story. TI's domestic manufacturing shields it from the tariff concerns plaguing competitors with Asian supply chains. 10 stocks we like better than Texas Instruments › Shares of Texas Instruments (NASDAQ: TXN) ended Wednesday's trading 9.9% above Tuesday's closing price. The semiconductor veteran reported Q4 2025 results on Tuesday evening, offering an unusual mix of hits and misses. A mixed earnings report with a silver lining Let's start with the usual headline figures. TI's revenue rose 10% year over year to $4.42 billion. The analyst consensus called for $4.45 billion, so it was a slight miss. Unadjusted earnings fell 2%, landing at $1.27 per diluted share. Here, Wall Street was looking for $1.29 per share. The bottom line included unexpected charges of $0.06 per share related to goodwill impairment and tax items. Without these one-time items, TI's earnings result would have been more than enough. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » So TI fell short of the usual market-moving targets. But investors were quick to brush off these minor disappointments to focus on several positive surprises instead. Guidance for the next quarter was consistently above the current Street projections. A new chip-making facility in Sherman, Texas, is ramping up production ahead of schedule. Among other items, this factory produces voltage regulators for high-powered computers, ultimately serving the lucrative data center market. That's an ideal segment for beating forecasts. Data center orders rose by a staggering 70% year over year. That wasn't even a reporting segment last year. Still, the data center business is now large enough to deserve its own year-end commentary with detailed financia...
Chawalit Banpot/iStock via Getty Images Cullinan Therapeutics, Inc. ( CGEM ) is a clinical-stage drug developer that focuses on a wholly owned pipeline. They have bispecific T-cell engagers for autoimmune and blood cancer treatments, combined with a late-stage partnered lung cancer asset: zipalertinib. CGEM and Taiho have initiated a rolling NDA for zipalertinib for non-small cell lung cancer (NSC...
Chawalit Banpot/iStock via Getty Images Cullinan Therapeutics, Inc. ( CGEM ) is a clinical-stage drug developer that focuses on a wholly owned pipeline. They have bispecific T-cell engagers for autoimmune and blood cancer treatments, combined with a late-stage partnered lung cancer asset: zipalertinib. CGEM and Taiho have initiated a rolling NDA for zipalertinib for non-small cell lung cancer (NSCLC) and expect to finish the submission in Q1 2026. Thus, I think CGEM continues to make promising progress across its pipeline. And coupled with its robust balance sheet and reasonable valuation, I think the stock remains a great speculative “Buy” at these levels. Promising Oncology Progress Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops oncology and immunology therapies. It was founded back in 2016 and is currently headquartered in Cambridge, Massachusetts. I previously covered CGEM in July last year with a “BUY” rating. Since then, the stock has appreciated by almost 65.6%, so I thought it was worthwhile writing an update on this name. Source: Corporate Presentation. January 2026. As a quick recap, CGEM’s pipeline has a wholly owned bispecific T cell engager program targeting autoimmune diseases and blood cancer. They also have a small-molecule program in lung cancer developed in partnership with Taiho Oncology, a subsidiary of the Japanese Taiho Pharmaceutical Co. Having said that, their T cell engager program is a bispecific antibody-like drug that binds CD3 on T cells to activate them while simultaneously binding a disease target on the harmful cell. This way, CGEM can bring T cells into close contact and can kill the target cells. This program includes CLN-978 for autoimmune conditions and CLN-049 for acute myeloid leukemia (AML). Source: Corporate Presentation. January 2026. Moreover, CLN-978 is in Phase 1 for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and Sjögren’s disease (SjD), with initial data in 1H20...
Low-cost Southeast Asian carrier AirAsia is close to finalizing an order for around 100 Airbus SE regional jets, according to people familiar with the matter, as the airline looks to expand its operations. The companies have agreed on terms and an announcement may come as soon as this week, said the people, who asked not to be identified because the talks are confidential. The timing of the deal i...
Low-cost Southeast Asian carrier AirAsia is close to finalizing an order for around 100 Airbus SE regional jets, according to people familiar with the matter, as the airline looks to expand its operations. The companies have agreed on terms and an announcement may come as soon as this week, said the people, who asked not to be identified because the talks are confidential. The timing of the deal is still subject to change, they said. A 100-jet order would be the single largest purchase of A220 aircraft ever. AirAsia is considering options that could push the total size of the commitment to 150 jets, the people said. Representatives for AirAsia and Airbus declined to comment. Reuters previously reported on the potential order. AirAsia, overseen by Malaysian businessman Tony Fernandes , is pushing hard on expansion plans after scaling back operations and restructuring its finances during the Covid pandemic. Beyond its regional Asian market, the airline is set to start its Middle East hub in Bahrain as early as this year, which will act as a launching pad for transit flights into Europe. Read More: AirAsia Seeks To Start Bahrain Hub This Year, Deputy CEO Says AirAsia operates an all-Airbus fleet with about 250 mostly single-aisle aircraft, and has a backlog of almost 400 orders comprised mostly of the top-selling A320 family of jets. The low-cost carrier tentatively agreed last summer to buy up to 70 of the extra long-range A321neo jets in a $12.3 billion pact, while phasing out its widebody fleet. The A220 deal has been long in the making, with negotiations stretching back into the early part of last year. The model, which can seat between 100 and 160 passengers, is smaller than what AirAsia usually flies but would enable it to operate from smaller airports and in markets that have less demand for traditional single-aisle jets. A three-digit order haul for Airbus’s smallest commercial jet would be a major boost to the A220 program, which has been beset by slow sales a...
Earnings Call Insights: C.H. Robinson Worldwide, Inc. (CHRW) Q4 2025 Management View David Bozeman, President and CEO, opened by highlighting, “The fourth quarter certainly provided a challenging macro environment with weak global freight demand, rising spot costs in trucking and falling ocean rates all providing headwinds to our business.” He emphasized that despite these pressures, “we grew our ...
Earnings Call Insights: C.H. Robinson Worldwide, Inc. (CHRW) Q4 2025 Management View David Bozeman, President and CEO, opened by highlighting, “The fourth quarter certainly provided a challenging macro environment with weak global freight demand, rising spot costs in trucking and falling ocean rates all providing headwinds to our business.” He emphasized that despite these pressures, “we grew our total volume by 1% and our truckload volume by approximately 3% on a year-over-year basis compared to a 7.6% year-over-year decline in the Cass Freight Shipment Index. This reflects another quarter of demonstrable market share growth.” Bozeman stressed the ongoing transformation, stating, “We are using our trusted domain expertise, to build technology that delivers on our customer promise and drives higher value for all of our stakeholders.” He underscored the company’s commitment to scaling Lean AI initiatives, noting, “Significant runway exists as we continue to deepen the Lean mindset and scale custom-built AI agents across the enterprise.” Damon Lee, Chief Financial Officer, stated, “Q4 personnel expenses were $337 million, including $15.2 million of restructuring charges related to workforce reductions. Excluding restructuring charges in 2025 and 2024, our Q4 personnel expenses were $321.8 million, down $28.8 million or 8.2% due to our continued productivity and cost optimization efforts and the divestiture of our Europe Surface Transportation business.” Lee added, “As a result of our efforts to grow market share, improve gross margins and increase our productivity and operating leverage, we expanded our operating margin, excluding restructuring costs, by 320 basis points year-over-year.” Michael Castagnetto, President of North American Surface Transportation, detailed market share gains, saying, “For the 11th consecutive quarter, the team delivered market share growth in Q4... our combined truckload and LTL volume delivered positive growth of approximately 1% year-ove...